The pending sale of STAAR Surgical Company (NASDAQ:STAA) to Alcon Inc. (NYSE:ALC) has taken an unusual turn. In April 2024, the implantable lens maker rejected a $58-per-share takeover bid from Alcon.

RH (RH) on Thursday reported fiscal second-quarter profit of $51.7 million. The Corte Madera, California-based company said it had profit of $2.62 per share.